Tiziana Life Sciences TLSA
NASDAQ TLSA
$0.96 -0.01 (-1.30%)
At close: Sep 10, 2026 · 4:00 PM EDT

Tiziana Life Sciences (TLSA) Assets Average (2018 - 2025)

Tiziana Life Sciences (TLSA) posted Assets Average of $14.0 million for Q4 2025, up 0.76% on a QoQ basis from $13.9 million in Q2 2025, and up 26.27% year-over-year from $11.1 million in Q4 2024.

Analysis

Tiziana Life Sciences (TLSA) Assets Average (2018 - 2025) Analysis & Trends

Tiziana Life Sciences has reported Assets Average for 8 years, with the latest figure at $14.0 million in Q4 2025.

  • On a quarterly basis, Assets Average rose 26.27% year-over-year to $14.0 million in Q4 2025; TTM through Dec 2025 was $14.0 million, a 26.27% increase from a year earlier, with the FY2025 full-year figure at $11.4 million, down 2.94% from the prior year.
  • Assets Average was $14.0 million for Q4 2025 at Tiziana Life Sciences, up from $13.9 million in the prior quarter.
  • The five-year high for Assets Average was $64.3 million in Q2 2021, with the low at $11.1 million in Q4 2024.
  • Average Assets Average over 5 years is $27.8 million, with a median of $18.4 million recorded in 2023.
  • The sharpest annual moves came in 2021 and 2023: Assets Average soared 737.15% in 2021, then slumped 51.95% in 2023.
  • Over 5 years, Assets Average stood at $53.3 million in 2021, then tumbled by 42.26% to $30.8 million in 2022, then tumbled by 51.95% to $14.8 million in 2023, then slipped by 24.84% to $11.1 million in 2024, then advanced by 26.27% to $14.0 million in 2025.
  • The last three Assets Average figures came in at $14.0 million (Q4 2025), $13.9 million (Q2 2025), and $11.1 million (Q4 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 5.34 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 30.78 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 5.51 Bn
10 Tiziana Life Sciences 113.92 Mn 113.92 Mn - 14.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 14.05 Mn
Jun 30, 2025 13.94 Mn
Dec 31, 2024 11.12 Mn
Jun 30, 2024 11.57 Mn
Dec 31, 2023 14.80 Mn
Jun 30, 2023 21.95 Mn
Dec 31, 2022 30.80 Mn
Jun 30, 2022 41.98 Mn
Dec 31, 2021 53.35 Mn
Jun 30, 2021 64.26 Mn
Dec 31, 2020 41.84 Mn
Jun 30, 2020 7.68 Mn
Dec 31, 2019 2.51 Mn
Jun 30, 2019 4.85 Mn
Dec 31, 2018 4.39 Mn
Jun 30, 2018 2.11 Mn